Xeris Biopharma Holdings Balance Sheet Health
Financial Health criteria checks 2/6
Xeris Biopharma Holdings has a total shareholder equity of $-6.8M and total debt of $190.9M, which brings its debt-to-equity ratio to -2815.3%. Its total assets and total liabilities are $322.6M and $329.4M respectively.
Key information
-2,815.3%
Debt to equity ratio
US$190.93m
Debt
| Interest coverage ratio | n/a |
| Cash | US$72.45m |
| Equity | -US$6.78m |
| Total liabilities | US$329.38m |
| Total assets | US$322.60m |
Recent financial health updates
No updates
Recent updates
Xeris Biopharma: Checking-In On One Of My 'Top Ideas'
Mar 30Analysts Are Updating Their Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Estimates After Its Full-Year Results
Mar 09
Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) Shares Climb 26% But Its Business Is Yet to Catch Up
Mar 06Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Shares Fly 32% But Investors Aren't Buying For Growth
Jan 05Xeris Pharmaceuticals Q2 2022 Earnings Preview
Aug 09Xeris amends commercial terms for hypoglycemia therapy as partner inks buyout deal
Aug 01Xeris Biopharma: Q1 Earnings Reveal Path To Breakeven
May 21Xeris Continues To Execute And Build Long-Term Value Potential
Feb 22Xeris Biopharma: Market Is Snubbing The Strongbridge Acquisition
Dec 20Financial Position Analysis
Short Term Liabilities: XERS has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: XERS has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: XERS has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: XERS's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: XERS has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: XERS has sufficient cash runway for 1.2 years if free cash flow continues to reduce at historical rates of 8.6% each year.